(Q36304424)

13 August 2017

1 reference

title

Coinfection with HIV and hepatitis C virus in injection drug users and minority populations (English)

1 reference

13 August 2017

0 references

1 reference

1 reference

Doris B Strader

1

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

Clinical Infectious Diseases

13 August 2017

published in

1 reference

13 August 2017

volume

41 Suppl 1

1 reference

13 August 2017

page(s)

S7-13

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

13 August 2017

cites work

1 reference

Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group

21 January 2018

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

21 January 2018

1 reference

Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection

21 January 2018

1 reference

Hepatitis C and progression of HIV disease

21 January 2018

1 reference

Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study

21 January 2018

1 reference

Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

21 January 2018

1 reference

Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission

21 January 2018

1 reference

Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study

21 January 2018

1 reference

Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users

21 January 2018

1 reference

HIV and hepatitis C coinfection within the CAESAR study

21 January 2018

1 reference

Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management

21 January 2018

1 reference

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

21 January 2018

1 reference

Community-based survey of HCV and HIV coinfection in injection drug abusers in Sichuan Province of China

21 January 2018

1 reference

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

21 January 2018

1 reference

Protection against persistence of hepatitis C.

21 January 2018

1 reference

The natural history of hepatitis C virus infection: host, viral, and environmental factors

21 January 2018

1 reference

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

21 January 2018

1 reference

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

21 January 2018

1 reference

Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection

21 January 2018

1 reference

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

21 January 2018

1 reference

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

The progression of HCV-associated liver disease in a cohort of haemophilic patients

21 January 2018

1 reference

Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C.

21 January 2018

1 reference

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

21 January 2018

1 reference

Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?

21 January 2018

1 reference

Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects

21 January 2018

1 reference

Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy

21 January 2018

1 reference

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections

21 January 2018

1 reference

Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy

21 January 2018

1 reference

Short communication: liver toxicity of lopinavir-containing regimens in HIV-infected patients with or without hepatitis C coinfection

21 January 2018

1 reference

Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group

21 January 2018

1 reference

Antiretroviral drug toxicity -- a challenge for the hepatologist?

21 January 2018

1 reference

Adverse effects of antiretroviral therapy

21 January 2018

1 reference

Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.

21 January 2018

1 reference

HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus

21 January 2018

1 reference

Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection

21 January 2018

1 reference

Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report

21 January 2018

1 reference

Pilot study of interferon alpha high-dose induction therapy in combination with ribavirin for chronic hepatitis C in HIV-co-infected patients.

21 January 2018

1 reference

Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

21 January 2018

1 reference

Treatment of chronic hepatitis C in HIV/HCV-coinfection with interferon alpha-2b+ full-course vs. 16-week delayed ribavirin

21 January 2018

1 reference

Human immunodeficiency virus infection, anemia, and survival

21 January 2018

1 reference

Hepatitis C virus/human immunodeficiency virus coinfection: clinical management issues

21 January 2018

1 reference

Ribavirin antagonizes the effect of azidothymidine on HIV replication

21 January 2018

1 reference

Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection

21 January 2018

1 reference

Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment.

21 January 2018

1 reference

Treatment of hepatitis C infection in injection drug users

21 January 2018

1 reference

Treating hepatitis C in methadone maintenance patients: an interim analysis

21 January 2018

1 reference

Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up

21 January 2018

1 reference

The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians

21 January 2018

1 reference

Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin

21 January 2018

1 reference

Treatment of chronic hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response?

21 January 2018

1 reference

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/429489

1 reference

13 August 2017

1 reference